Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1988 Dec;74(3):339–343.

Immunopotentiation by orally-administered Quillaja saponins: effects in mice vaccinated intraperitoneally against rabies.

S R Chavali 1, L D Barton 1, J B Campbell 1
PMCID: PMC1542014  PMID: 3233788

Abstract

Orally fed Quillaja saponins amplified the immunopotentiating ability of an intraperitoneally (IP) administered inactivated rabies vaccine in mice. The number of animals surviving rabies infection was markedly higher (90-100%) in groups of animals receiving a combined treatment of oral saponin (SAP) and IP vaccine, compared to groups receiving vaccine alone (25%), or to unimmunized mice (0%). Antibody production was significantly higher in animals fed SAP 2 weeks after primary or secondary sensitization with an IP-injected vaccine. In mice given 2 IP doses of vaccine, 1 week apart, simultaneous feeding of SAP resulted in an enhanced production of rabies-specific (whole Ig) antibodies. On the other hand, animals preconditioned with SAP 3 days prior to administration of the vaccine exhibited greatly increased IgG antibody levels. Moreover, SAP-preconditioned mice vaccinated with a very low dosage produced significantly higher levels of antibodies.

Full text

PDF
339

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C., Byars N. E. An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. J Immunol Methods. 1986 Dec 24;95(2):157–168. doi: 10.1016/0022-1759(86)90402-3. [DOI] [PubMed] [Google Scholar]
  2. Barton L. D., Campbell J. B. Measurement of rabies-specific antibodies in carnivores by an enzyme-linked immunosorbent assay. J Wildl Dis. 1988 Apr;24(2):246–258. doi: 10.7589/0090-3558-24.2.246. [DOI] [PubMed] [Google Scholar]
  3. Bomford R. Studies on the cellular site of action of the adjuvant activity of saponin for sheep erythrocytes. Int Arch Allergy Appl Immunol. 1982;67(2):127–131. doi: 10.1159/000233002. [DOI] [PubMed] [Google Scholar]
  4. Chavali S. R., Campbell J. B. Adjuvant effects of orally administered saponins on humoral and cellular immune responses in mice. Immunobiology. 1987 May;174(3):347–359. doi: 10.1016/s0171-2985(87)80009-8. [DOI] [PubMed] [Google Scholar]
  5. Chavali S. R., Campbell J. B. Immunomodulatory effects of orally-administered saponins and nonspecific resistance against rabies infection. Int Arch Allergy Appl Immunol. 1987;84(2):129–134. doi: 10.1159/000234411. [DOI] [PubMed] [Google Scholar]
  6. Chavali S. R., Francis T., Campbell J. B. An in vitro study of immunomodulatory effects of some saponins. Int J Immunopharmacol. 1987;9(6):675–683. doi: 10.1016/0192-0561(87)90038-5. [DOI] [PubMed] [Google Scholar]
  7. Doherty P. C. T cells and viral infections. Br Med Bull. 1985 Jan;41(1):7–14. doi: 10.1093/oxfordjournals.bmb.a072028. [DOI] [PubMed] [Google Scholar]
  8. Drake J. J., Butterworth K. R., Gaunt I. F., Hooson J., Evans J. G., Gangolli S. D. Long-term toxicity study quillaia extract in rats. Food Chem Toxicol. 1982 Feb;20(1):15–23. doi: 10.1016/s0278-6915(82)80004-5. [DOI] [PubMed] [Google Scholar]
  9. Fenwick D. E., Oakenfull D. Saponin content of food plants and some prepared foods. J Sci Food Agric. 1983 Feb;34(2):186–191. doi: 10.1002/jsfa.2740340212. [DOI] [PubMed] [Google Scholar]
  10. Flebbe L. M., Braley-Mullen H. Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. Cell Immunol. 1986 Apr 15;99(1):119–127. doi: 10.1016/0008-8749(86)90221-2. [DOI] [PubMed] [Google Scholar]
  11. Flebbe L. M., Braley-Mullen H. Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations. Cell Immunol. 1986 Apr 15;99(1):128–139. doi: 10.1016/0008-8749(86)90222-4. [DOI] [PubMed] [Google Scholar]
  12. Jie Y. H., Cammisuli S., Baggiolini M. Immunomodulatory effects of Panax Ginseng C.A. Meyer in the mouse. Agents Actions. 1984 Oct;15(3-4):386–391. doi: 10.1007/BF01972376. [DOI] [PubMed] [Google Scholar]
  13. Maharaj I., Froh K. J., Campbell J. B. Immune responses of mice to inactivated rabies vaccine administered orally: potentiation by Quillaja saponin. Can J Microbiol. 1986 May;32(5):414–420. doi: 10.1139/m86-078. [DOI] [PubMed] [Google Scholar]
  14. McColm A. A., Bomford R., Dalton L. A comparison of saponin with other adjuvants for the potentiation of protective immunity by a killed Plasmodium yoelii vaccine in the mouse. Parasite Immunol. 1982 Sep;4(5):337–347. doi: 10.1111/j.1365-3024.1982.tb00445.x. [DOI] [PubMed] [Google Scholar]
  15. Murphy F. A. Rabies pathogenesis. Arch Virol. 1977;54(4):279–297. doi: 10.1007/BF01314774. [DOI] [PubMed] [Google Scholar]
  16. Phillips J. C., Butterworth K. R., Gaunt I. F., Evans J. G., Grasso P. Long-term toxicity study of quillaia extract in mice. Food Cosmet Toxicol. 1979 Feb;17(1):23–27. doi: 10.1016/0015-6264(79)90154-8. [DOI] [PubMed] [Google Scholar]
  17. Price K. R., Johnson I. T., Fenwick G. R. The chemistry and biological significance of saponins in foods and feedingstuffs. Crit Rev Food Sci Nutr. 1987;26(1):27–135. doi: 10.1080/10408398709527461. [DOI] [PubMed] [Google Scholar]
  18. Schneider L. G., Horzinek M., Novický R. Isolation of a hemagglutinating, immunizing, and non-infectious subunit of the rabies virion. Arch Gesamte Virusforsch. 1971;34(4):360–370. doi: 10.1007/BF01242983. [DOI] [PubMed] [Google Scholar]
  19. Scott M. T., Bahr G., Moddaber F., Afchain D., Chedid L. Adjuvant requirements for protective immunization of mice using a Trypanosoma cruzi 90K cell surface glycoprotein. Int Arch Allergy Appl Immunol. 1984;74(4):373–377. doi: 10.1159/000233576. [DOI] [PubMed] [Google Scholar]
  20. Singh V. K., George C. X., Singh N., Agarwal S. S., Gupta B. M. Combined treatment of mice with Panax ginseng extract and interferon inducer. Amplification of host resistance to Semliki forest virus. Planta Med. 1983 Apr;47(4):234–236. doi: 10.1055/s-2007-969995. [DOI] [PubMed] [Google Scholar]
  21. Turner G. S. Immunoglobulin (IgG) and (IgM) antibody responses to rabies vaccine. J Gen Virol. 1978 Sep;40(3):595–604. doi: 10.1099/0022-1317-40-3-595. [DOI] [PubMed] [Google Scholar]
  22. Wiktor T. J., Doherty P. C., Koprowski H. In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc Natl Acad Sci U S A. 1977 Jan;74(1):334–338. doi: 10.1073/pnas.74.1.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wiktor T. J., Doherty P. C., Koprowski H. Suppression of cell-mediated immunity by street rabies virus. J Exp Med. 1977 Jun 1;145(6):1617–1622. doi: 10.1084/jem.145.6.1617. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES